Search For "vaccine"
DCGI gives nod to Serum Institute to hold Phase II, III COVID vaccine tria
Updated : 5 years, 7 months ago IST
New Delhi [India], Aug 3 (ANI): The Drugs Controller General of India (DCGI) gave approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India, said the Ministry of Health and Family Welfare on
Read More
No silver bullet for COVID-19 at present, there might never be: WHO
Updated : 5 years, 7 months ago IST
Geneva [Switzerland], Aug 3 (ANI): A number of coronavirus vaccines are now in phase three of clinical trials but "there's no silver bullet at the moment and there might never be," Tedros Adhanom Ghebreyesus, World Health Organisation Director-General said on Monday.
Read More
A modern technique, eVIN, ensured essential immunisation services: Healthy
Updated : 5 years, 7 months ago IST
New Delhi [India], Aug 3 (ANI): An innovative technology called the Electronic Vaccine Intelligence Network (eVIN) has ensured essential immunisation services, said the Union Ministry of Health and Family Welfare on Monday.
Read More
Wockhardt announces Covid-19 vaccine partnership with UK government
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], Aug 3 (ANI): Pharmaceutical and biotechnology major Wockhardt said on Monday it has entered into an agreement with the UK Government to fill-finish Covid-19 vaccines.
Read More
DCGI nod to Serum-Oxford COVID19 vaccine for phase 2, 3 clinical trials in
Updated : 5 years, 7 months ago IST
New Delhi, [India], Aug 3 (ANI) India's top drug regulator-- Drugs Controller General of India (DCGI) has granted permission to Serum Institute of India (SII) to conduct phase 2 and 3 human clinical trials in India on the potential COVID19 vaccine, a senior government official said.
Read More
Drug regulator gets committee approval for nod to clinical trials by Serum
Updated : 5 years, 7 months ago IST
New Delhi [India], July 31 (ANI): The Subject Expert Committee at Central Drugs Standard Control Organisation (CDSCO) has recommended to the top drug regulator to grant permission to Serum Institute of India (SII) to conduct phase two and three clinical trials in India on a potential COVID-1
Read More
Indian health-tech pioneer develops the world's first digital vaccine cand
Updated : 5 years, 7 months ago IST
New Delhi [India] July 31 (ANI/Digpu): In the global race against time for a COVID-19 vaccine, this could be a game-changing scientific breakthrough. Indian serial entrepreneur and investor, Bhargav Sri Prakash, Founder & CEO of health tech pioneer, FriendsLearn have expanded a longstand
Read More
US vaccinates 'several hundred' people in first days of phase 3 COVID-19 t
Updated : 5 years, 7 months ago IST
Washington D.C. [US], July 31 (Sputnik/ANI): The United States vaccinated several hundred volunteers during the first days of two Phase 3 COVID-19 vaccine trials, senior administration official told reporters.
Read More
COVID-19 vaccine development: Only 3 vaccine candidates in phase III acros
Updated : 5 years, 7 months ago IST
New Delhi [India], July 30 (ANI): In the development related to the COVID-19 vaccine across the world, only three vaccine candidates are in phase III clinical trials across the globe. These three coronavirus vaccine candidates are from the USA, UK (University of Oxford's vaccine) and Chin
Read More
University of Texas contacted by FBI over allegations that Chinese consula
Updated : 5 years, 7 months ago IST
Washington D.C. [US], July 30 (ANI): Amid worsening ties between US and China, the University of Texas, whose work has contributed to some promising COVID-19 vaccine candidates has been contacted by FBI over allegations that Chinese consulate in Houston had sought to obtain such research, re
Read More
ICMR to conduct International Symposium on ethics of vaccines against COVI
Updated : 5 years, 7 months ago IST
New Delhi [India], July 30 (ANI): The Indian Council of Medical Research (ICMR) will conduct the International Symposium on Novel Ideas in Science and Ethics of Vaccines Against COVID-19 Pandemic on July 30.
Read More
Drug Regulator asks Serum Institute to furnish revised protocol for COVID-
Updated : 5 years, 7 months ago IST
New Delhi [India], July 29 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has advised the Serum Institute of India (SII) to submit a revised protocol to perform the clinical trials in India for potential COVID-19 vaccine.
Read More